Recombinant Mouse CD42b/GPIb alpha Protein, CF

Recombinant Mouse CD42b/GPIb alpha Protein, CF Summary

Product Specifications

Product Datasheets

Carrier Free

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

Background: CD42b/GPIb alpha

Platelet glycoprotein Ib alpha chain (GPIb alpha ), also known as CD42b, is a 145 kDa type I transmembrane member of the leucine-rich repeat (LRR) family of ligand binding proteins (1-3). Mature mouse GPIb alpha contains a 596 amino acid (aa) extracellular domain (ECD), a 21 aa transmembrane domain, and a 101 aa cytoplasmic region. The ECD of mouse GPIb alpha shares 48% and 51% aa sequence identity with human and rat GPIb alpha respectively. GPIb alpha is expressed by platelets and functions as the ligand-binding component of the platelet GPIb-IX-V complex (4). LRR2 and 4 of the extracellular domain (ECD) of GPIb alpha will trigger von Willebrand factor (vWF)-dependent adhesion of platelets to the vascular endothelium under high shear stress conditions (5, 6). Furthermore, the C-terminal anionic flanking region of the LRRs contains three tyrosine residues that are post-translationally sulfated. This modification is essential for GPIb alpha binding to vWF and Thrombin (7). The C-terminal anionic region also contains a sialomucin domain with N- and O-linked carbohydrates, and two cysteines near the membrane that allow dimerization with GP1b beta (1-6). Four additional human isoforms are generated with 1-4 repeats of aa 398-411 within the sialomucin domain of mature GPIb alpha (8). The metalloproteinase TACE/ADAM17 constitutively and inducibly cleaves GPIb alpha and releases a soluble circulating form called Glycocalicin (9, 10). GPIb alpha binding to ligands such as Thrombin, Kininogen, and Coagulation Factors XI and XII helps to initiate platelet activation and coordinate the coagulation cascade (1, 11-13). Binding to vWF or Thrombospondin in the plasma or matrix, vWF or P-Selectin on endothelial cells, or the Integrin alpha M beta 2 (MAC-1) on myeloid cells, controls responses to vascular injury (1, 14). Bernard-Soulier syndrome and platelet-type von Willebrand disease are platelet function disorders that can be caused by mutations in GPIb alpha (1, 15).

Related Research Areas

• Coagulation
• Myeloid Lineage Markers
• Platelet Adhesion Molecules
• Platelet Markers